Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$0.79 - $2.83 $7,805 - $27,960
-9,880 Reduced 40.73%
14,377 $12,000
Q3 2023

Nov 14, 2023

BUY
$0.79 - $2.83 $7,805 - $27,960
9,880 Added 68.72%
24,257 $3.99 Million
Q2 2020

Aug 05, 2020

SELL
$32.57 - $42.83 $4,559 - $5,996
-140 Reduced 0.96%
14,377 $583,000
Q2 2019

Jul 31, 2019

SELL
$35.13 - $55.53 $243,486 - $384,878
-6,931 Reduced 32.32%
14,517 $656,000
Q1 2019

Apr 30, 2019

BUY
$42.83 - $59.91 $599,962 - $839,219
14,008 Added 188.28%
21,448 $1.17 Million
Q4 2017

Feb 02, 2018

BUY
$41.95 - $60.1 $312,108 - $447,144
7,440
7,440 $353,000

Others Institutions Holding FGEN

About FIBROGEN INC


  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $32.8M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Public Employees Retirement Association Of Colorado Portfolio

Follow Public Employees Retirement Association Of Colorado and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Employees Retirement Association Of Colorado, based on Form 13F filings with the SEC.

News

Stay updated on Public Employees Retirement Association Of Colorado with notifications on news.